Stuart Green

Prof. Stuart Green

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in The Lancet Oncology
Verified
Journal Article
Closed access
HKHyoung Jin Kang
Hyoung Jin Kang
SLSusan Loftus
Susan Loftus
ATArlene Taylor
Arlene Taylor
CDCara DiCristina
Cara DiCristina
SGStuart Green
Stuart Green
CZChristian Michel Zwaan
Christian Michel Zwaan

1 July 2016 in British Journal of Radiology
Verified
Journal Article
Open access
MPMichael J Parkes
Michael J Parkes
SGStuart Green
Stuart Green
ASAndrea M Stevens
Andrea M Stevens
SPSophia Parveen
Sophia Parveen
RSRebecca Stephens
Rebecca Stephens
TCThomas H Clutton-Brock
Thomas H Clutton-Brock
Objective:Multiple, short and deep inspiratory breath-holds with air of approximately 20 s are now used in radiotherapy to reduce the influence of ventilatory motion and damage to healthy tissue. There may be further clinical advantages in delivering each treatment session in only one single, prolonged breath-hold. We have previously developed techniques enabling healthy subjects to breath-hold for 7 min. Here, we demonstrate their successful application in patients with cancer.Methods:15 patients aged 37–74 years undergoing radiotherapy for breast cancer were trained to breath-hold safely with pre-oxygenation and mechanically induced hypocapnia under simulated radiotherapy treatment conditions.Results:The mean breath-hold duration was 5.3 ± 0.2 min. At breakpoint, all patients were normocapnic and normoxic [mean end-tidal partial pressure of carbon dioxide was 36 ± 1 standard error millimetre of mercury, (mmHg) and mean oxygen saturation was 100 ± 0 standard error %]. None were distressed, nor had gaspin...

1 June 2019 in Pulmonary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
DMDavid Muccino
David Muccino
SGStuart Green
Stuart Green

5 January 2025 in Applied Radiation and Isotopes
Verified
Journal Article
Open access
SGStuart Green
Stuart Green
BPBen Phoenix
Ben Phoenix
SNSatoshi Nakamura
Satoshi Nakamura
YLYuan Hao Liu
Yuan Hao Liu
DSDiyun Shu
Diyun Shu
HTHiroki Tanaka
Hiroki Tanaka
Recent decades have seen the development of accelerator neutron sources suitable for installation in a hospital setting. Numerous challenges have been faced and solved to deliver technology which continues to transform the field of BNCT. This paper begins by briefly reviewing the technologies which are currently, or soon will be, in clinical use. This is followed by discussion of the thermal neutron fluence distributions produced by these accelerator sources and their associated beam shaping assemblies. This is illustrated by basic physics simulations of monoenergetic neutron fields, followed by some broad comparisons of the published distributions of thermal fluence produced by the different available technologies. It will be argued that these distributions have a high degree of similarity and that this similarity that can be helpful as the field of BNCT matures. Finally some aspects of the design of beam shaping assemblies and beam collimation will be discussed, and how this may enhance the capability of BNCT for verification of the delivered dose via the measurement of the prompt gammas emitted by the 10B (n, alpha) 7Li reaction. In particular the directionality of the beam will be discussed and measures that those designing beam shaping assemblies might consider to increase/improve beam directionality.

1 June 2016 in British Journal of Radiology
Verified
Journal Article
Open access
MPMichael J Parkes
Michael J Parkes
SGStuart Green
Stuart Green
ASAndrea M Stevens
Andrea M Stevens
SPSophia Parveen
Sophia Parveen
RSRebecca Stephens
Rebecca Stephens
TCThomas H Clutton-Brock
Thomas H Clutton-Brock
Objective:Variability in the breathing pattern of patients with cancer during radiotherapy requires mitigation, including enlargement of the planned treatment field, treatment gating and breathing guidance interventions. Here, we provide the first demonstration of how easy it is to mechanically ventilate patients with breast cancer while fully conscious and without sedation, and we quantify the resulting reduction in the variability of breathing.Methods:15 patients were trained for mechanical ventilation. Breathing was measured and the left breast anteroposterior displacement was measured using an Osiris surface-image mapping system (Qados Ltd, Sandhurst, UK).Results:Mechanical ventilation significantly reduced the within-breath variability of breathing frequency by 85% (p < 0.0001) and that of inflation volume by 29% (p < 0.006) when compared with their spontaneous breathing pattern. During mechanical ventilation, the mean amplitude of the left breast marker displacement was 5 ± 1 mm, the mean variabilit...

7 November 2011 in International Journal of Radiation Biology
Verified
Journal Article
Closed access
PDF file
AMAnna J. Mason
Anna J. Mason
VGValerio Giusti
Valerio Giusti
SGStuart Green
Stuart Green
PRPer Munck Af Rosenschöld
Per Munck Af Rosenschöld
TBT. Derek Beynon
T. Derek Beynon
John HopewellJohn Hopewell
John Hopewell
Purpose: The relative biological effectiveness of two epithermal neutron sources, a reactor based source at Studsvik, Sweden, and a proton accelerator-based source in Birmingham, UK, was studied in relation to the proportional absorbed dose distribution as a function of neutron energy. Evidence for any interactions between the effects of biological damage induced by high- and low-linear energy transfer (LET) dose components, in this ‘mixed field’ irradiation, was also examined Materials and methods: Clonogenic survival in Chinese Hamster-derived V79 cells was used to assess biological effectiveness in this study. Cells were irradiated in suspension at 4°C at depths of 20, 35, 50 and 65 mm in a water phantom. This prevented the repair of sublethal damage, predominantly that produced by both incident and induced γ-rays in the field, over the variable periods of exposure required to irradiate cells with the same total absorbed dose. Cell survival, as a function of the absorbed radiation dose and depth in the phantom, was compared with Monte Carlo N-Particle (MCNP) calculations of the proportional absorbed dose distribution as a function of neutron energy for the two sources. Results: In terms of the dose-related reduction in clonogenic cell survival, the epithermal neutron source at Studsvik was more biologically effective than the Birmingham source at all depths considered in the phantom. Although the contribution from the high-LET dose component was greater for the Studsvik source at 20 mm depth in the phantom, at greater depths the dose contribution from the high-LET dose component at Studsvik overlap with those for the Birmingham source. However, the most striking difference is in the fast neutron component to the dose of the two sources, neutron energies > 1 MeV were only associated with the Studsvik source. The relative biological effectiveness (RBE) of both sources declined slightly with depth in the phantom, as the total high-LET dose component declined. The maximum source RBE for Studsvik was 2.70 ± 0.50 at 20 mm; reduced to 2.10 ± 0.35 at depths of 50 and 65 mm. The corresponding values for Birmingham were 1.68 ± 0.25 and 1.31 ± 0.19, all values relate only to the surviving fraction of V79 cells at 37%, since RBE values are only applicable to the selected endpoint. Based on a dose reduction factor (DRF) of 1.0 for the total low-LET component to the absorbed dose, the RBE values for the high-LET dose component (fast neutrons and induced protons from the nitrogen capture reaction) was 14.5 and 7.05 for the Studsvik and Birmingham neutron sources, respectively. This is well outside the range of RBE historically reported values for V79 cells for the same level of cell survival for fast neutrons. The calculation of RBE values, based on the proportional absorbed dose distribution as a function of neutron energy, from historical data, and using a RBE of 1.8 for the dose from the nitrogen capture reaction, suggests RBE values for the total high-LET dose component of 3.1–2.8 and 2.5–2.0 for Studsvik and Birmingham, respectively, values again declining with depth in the phantom. Conclusions: The overall biological effectiveness of the mixed field irradiation from an epithermal neutron sources depends on the composition and quality of the different dose components. The experimentally derived RBE values for the total high-LET dose components in these ‘mixed field’ irradiations are well in excess of historical data for fast neutrons. The difference between the historically expected and the observed RBE values is attributed to the interactions between the damage produced by high- and low-LET radiation.